Delivery Order SPE2DB22D7058-SPE2DB23FV4ZH

Award Date 8/2/23
Potential Completion Date 8/3/23
Potential Value $33K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Defense Logistics Agency awarded a $26,437.76 firm fixed price delivery order to Amerisourcebergen Drug Corporation for DUPIXENT 300 MG/2 ML syringes. Amerisourcebergen, a subsidiary of Amerisourcebergen Corporation, will deliver the pharmaceutical products to a location in Conshohocken, Pennsylvania by August 24, 2023 in support of the Agency's medical supply needs. No set aside designation or subcontractors were indicated. The award is likely placed against DLA's Pharmaceutical Prime...
The Defense Logistics Agency awarded a $16,523.60 firm fixed price delivery order to Amerisourcebergen Drug Corporation for DUPIXENT 300 MG/2 ML syringes. Amerisourcebergen, a subsidiary of Amerisourcebergen Corporation, will deliver the pharmaceutical products to a location in Conshohocken, Pennsylvania by September 14, 2023 in support of DLA procurement programs. No set aside designation or subcontractors were identified. DLA manages the global supply chain for the Department of Defense,...
The Defense Logistics Agency awarded a $27,625.36 firm fixed-price delivery order to Amerisourcebergen Drug Corporation for DUPIXENT 300 MG/2 ML syringes. Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, will deliver the syringes to a location in Conshohocken, Pennsylvania by September 27, 2023 to support DLA programs. No set-aside designation or subcontractors were identified. DLA manages the global supply chain for the Department of Defense, procuring medical...
The Defense Logistics Agency awarded a $27,916 firm fixed price delivery order to Amerisourcebergen Drug Corporation for DUPIXENT 300 MG/2 ML syringes. Amerisourcebergen, a subsidiary of Amerisourcebergen Corporation, will deliver the pharmaceutical products to a location in Conshohocken, Pennsylvania by July 11, 2023 in support of Department of Defense requirements. No set aside designation or subcontractors were identified. The Defense Logistics Agency manages the global supply chain for the...
The Defense Logistics Agency awarded a $24,660 firm fixed price delivery order to Amerisourcebergen Drug Corporation for DUPIXENT 300 MG/2 ML syringes. Amerisourcebergen, a subsidiary of Amerisourcebergen Corporation, will deliver the pharmaceutical products to a location in Conshohocken, Pennsylvania by September 11, 2023 in support of Department of Defense requirements. No set aside designation or subcontracting details were provided. The Defense Logistics Agency manages the global supply...
The Defense Logistics Agency awarded a $22,129.99 firm fixed price delivery order to Amerisourcebergen Drug Corporation for DUPIXENT 300 MG/2 ML syringes. Amerisourcebergen, a subsidiary of Amerisourcebergen Corporation, will deliver the pharmaceutical products to a location in Conshohocken, Pennsylvania by August 22, 2023 in support of the Defense Logistics Agency's medical supply chain responsibilities. No subcontractors or set aside designations were identified in the award information.
The Defense Logistics Agency awarded a $4,415.20 firm fixed price delivery order to Amerisourcebergen Drug Corporation for DUPIXENT 300 MG/2 ML syringes. Amerisourcebergen Drug, a division of Amerisourcebergen Corporation, will deliver the specified pharmaceutical product to a location in Conshohocken, Pennsylvania by August 25, 2023 in support of DLA requirements. No set aside designation or subcontracting details were provided. DLA manages the global supply chain for the Department of Defense,...
The Defense Logistics Agency awarded a $9,914.16 firm fixed price delivery order to Amerisourcebergen Drug Corporation for DUPIXENT 300 MG/2 ML syringes. Amerisourcebergen, a subsidiary of Amerisourcebergen Corporation, will deliver the pharmaceutical products to a location in Conshohocken, Pennsylvania by September 13, 2023 in support of the Agency's medical supply needs. No set aside designation or subcontractors were identified. The Defense Logistics Agency functions include procuring and...
<p>The Defense Logistics Agency awarded a $24,293.08 firm fixed price delivery order to Amerisourcebergen Drug Corporation for DUPIXENT 300 MG/2 ML syringes. Amerisourcebergen, a subsidiary of Amerisourcebergen Corporation, will deliver the pharmaceutical products to a location in Conshohocken, Pennsylvania by July 6, 2023 in support of the Defense Logistics Agency's medical supply chain responsibilities. No subcontractors or set aside designations were identified in the award information.</p>
The Defense Logistics Agency awarded a $23,349.76 firm fixed price delivery order to Amerisourcebergen Drug Corporation for DUPIXENT 300 MG/2 ML syringes. The contract calls for Amerisourcebergen to deliver the specified pharmaceutical product to a location in Conshohocken, Pennsylvania by July 12, 2023 to support the Department of Defense's medical supply needs. As a top vendor on the DLA's Pharmaceutical Prime Vendor contract, which manages pharmaceuticals for all branches of the armed forces,...
  • SPE2DB22D7058
    Indefinite Delivery Contract
  • SPE2DB22D7058-SPE2DB23FV4ZH
    Delivery Order

The Defense Logistics Agency awarded a $33,047.20 firm fixed price delivery order to Amerisourcebergen Drug Corporation for DUPIXENT 300 MG/2 ML syringes. Amerisourcebergen, a subsidiary of Amerisourcebergen Corporation, will deliver the pharmaceutical products to a location in Conshohocken, Pennsylvania by August 3, 2023 in support of the Agency's medical supply needs. No set aside designation or subcontractors were identified. The award is likely placed against DLA's pharmaceutical prime vendor contract vehicle to enable efficient distribution of prescription drugs and medications for military treatment facilities within the Defense Health Program.

Generated 12/19/23, 12:46 AM